Concepedia

Nathan R. Fons

NR

Statistics

Publications

4

Citations

679

H-Index

4

Active since

2017

Affiliations

Yale University(Current)

Yale Cancer Center

Nathan R. Fons is an author at Yale University specializing in molecular oncology, medicine, and oncology.

ORCID

Publications per year

2017–2022

4

Publications

4

2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity

Parker L. Sulkowski, Christopher D. Corso, Nathaniel D. Robinson et al. · Science Translational Medicine · 2017 · 564 citations

, , +17

PPM1D mutations silence NAPRT gene expression and confer NAMPT inhibitor sensitivity in glioma

Nathan R. Fons, Ranjini K. Sundaram, G. Breuer et al. · Nature Communications · 2019 · 74 citations · Full text

, , +17

Hair follicle regeneration suppresses Ras-driven oncogenic growth

Cristiana M. Pineda, David G. Gonzalez, Catherine Matte-Martone et al. · The Journal of Cell Biology · 2019 · 26 citations · Full text

, , +17

Chondroitin Sulfate Proteoglycans Are De Facto Cellular Receptors for Human Papillomavirus 16 under High Serum Conditions

Nathan R. Fons, Rhonda C. Kines, Cynthia D. Thompson et al. · Journal of Virology · 2022 · 15 citations · Full text

, , +17

1–4 of 4